Restoring Biological Harmony for Patients with Debilitating Disease

We are harnessing the power of microRNA science to develop therapies that normalize biological pathways and counterbalance disease.

Learn More

DEVELOPMENT PROGRAMS

Our pipeline is focused on serious diseases of high unmet need where the latest discoveries in microRNA biology are challenging traditional drug development paradigms and creating opportunities for novel therapeutic approaches.

Learn More

Recent Press Releases

August 7, 2018: miRagen Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
August 6, 2018: miRagen Therapeutics and The Leukemia & Lymphoma Society® Enter Into an Agreement to Facilitate the Development of Cobomarsen in Cutaneous T-Cell Lymphoma
July 31, 2018: miRagen Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference
July 25, 2018: miRagen Therapeutics to Report Second Quarter 2018 Financial Results and Host Conference Call on August 7, 2018
July 10, 2018: miRagen Therapeutics Announces Initiation of Phase 2 Clinical Trial of MRG-201

View All